Baxter International Inc
F:BTL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Baxter International Inc
F:BTL
|
US |
|
C
|
Cyfrowy Polsat SA
WSE:CPS
|
PL |
|
UniCredit SpA
F:CRIP
|
IT |
|
B
|
Bechtle AG
XMUN:BC8
|
DE |
|
S
|
Sixt SE
XMUN:SIX3
|
DE |
Intrinsic Value
Is BTL undervalued or overvalued?
See the intrinsic value estimate for 
Baxter International Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Baxter International Does
Baxter International makes medical products that hospitals and other care providers use to treat patients every day. Its lineup includes IV fluids, infusion pumps, drug-delivery systems, nutrition therapies, and disposable supplies that help doctors and nurses give medicines, fluids, and nutrition safely and consistently.
- Headquarters
- United States of America US
- Employees
- 37 500
- IPO date
- May 15, 1961
Baxter International has a narrow economic moat
Replacing equipment tied into hospital records and daily care routines takes money, staff training and careful testing. This gives Baxter a lasting foothold where hospitals already use its connected pumps, beds and communication systems, rather than protecting every product it sells.
Read the full moat analysis
Revenue & Expenses Breakdown
Baxter International Inc
Earnings Waterfall
Baxter International Inc
The intrinsic value for Baxter International Inc (BTL) under the Base Case is hidden EUR.
Compared with the current market price of 22.63 EUR, the stock appears hidden.